Lipoprotein Kinetics in T1D
University of Missouri-Columbia · with University of Washington · NCT05179954
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–45 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- May 9, 2022
- Record last updated
- February 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research study is to understand how type 1 diabetes (T1D) increases the risk for cardiovascular diseases (heart attack and stroke). To this end, the investigators will compare apolipoprotein and triglyceride kinetics in people wtih T1D and healthy control participants.
Being studied: Metabolic testing
Conditions: Type 1 Diabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age: ≥18 but ≤45 years
- premenopausal/eumenorrheic and not pregnant or breastfeeding
- non-obese (body mass index ≥18.5\<30.0 kg/m2)
- Fasting plasma triglyceride \<150 mg/dL
Additional inclusion criteria for control subjects:
- Fasting plasma glucose \<100 mg/dL
- Plasma glucose 2 h after a 75 g oral glucose challenge \<140 mg/dL
- HbA1c \<5.6%.
Additional inclusion criteria for subjects with T1DM:
- stable insulin regimen (multiple daily insulin injections or continuous subcutaneous insulin) for at least 8 weeks before screening
- no use of diabetes medications other than insulin
- HbA1c \<8.0%, basal (overnight fasted)
- no severe symptomatic hypoglycemic event associated with a seizure or requiring help from other people or a medical facility in the 6 months prior to screening or metabolic testing
Exclusion Criteria
- more than 1.5 h of structured exercise/week
- use of tobacco products, excessive amounts of alcohol, or dietary supplements and/or medications known to affect lipid metabolism
- hypothyroidism or other disorders known to affect lipid metabolism
- conditions that would make it impossible to complete the study protocol
Recruiting US locations
University of Missouri School of Medicine
Columbia, MO 65212
Site contact: Bettina Mittendorfer, PhD · b.mittendorfer@missouri.edu
Study contacts (from the official record)
- Amanda Heider · (573) 884-6852 · ahmc4@health.missouri.edu
- Mittendorfer Lab · MittendorferLab@umsystem.edu
Similar studies in Missouri
All diabetes studies in Missouri →- RecruitingHealthy volunteersOvernight stay mentioned
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Bettina Mittendorfer
- Location
- Columbia, MO
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersOvernight stay mentioned
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
Bettina Mittendorfer
- Location
- Columbia, MO
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Chesterfield, MO + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- St Louis, MO + 121 other US sites
- Eligibility basics
- Ages 55+